Rishabha Malviya, PhD, is Associate Professor of Pharmacy at the School of Medical and Allied Sciences, Galgotias University, Uttar Pradesh, India. He has authored many research and review papers and book chapters and edited over a dozen books. He also holds over 50 patents. He has been included in the World’s Top 2% Scientists list by Elsevier BV and Stanford University. He is a reviewer, editor, and editorial board member of more than 50 national and international journals.Pramod Kumar Srivastava, PhD, MBA, is Professor at the School of Business at Galgotias University, Greater Noida, India. He has over 16 years of experience in academics and research. He has organized and conducted management development programs, consultancy, seminars, conferences, NGO fairs, workshops, and counseling sessions and has prepared reports on feasibility of production units in India.Swati Verma, MPharm, is working in the Department of Pharmacy in the School of Medical and Allied Sciences at Galgotias University, Uttar Pradesh, India. Her areas of interest are computeraided drug design, analytical chemistry, targeted drug delivery, and nanoformulation. She has authored several book chapters and review papers and edited two books.Shashikant Srivastava, PhD, is Assistant Professor at the Indian Institute of Management, Sirmaur, India. He is a course instructor for subjects such as critical readings of seminal works (PhD), information technology concepts (MBA), big data analytics (MBA), and digital marketing analytics and optimization (MBA). His research expertise is in information economics, information security, data analytics, blockchain, organization and management theory, and technology and innovation management. His research expertise in these domains is both quantitative and qualitative. He has authored a number of papers in national and international journals.

"Of immense use as the authors highlight the overall ethnography of big pharma in the healthcare sector, with the opportunities and challenges in the outside world. I believe that after reading the book, readers will have a picture of the marketing strategies to be adopted to boost the pharmaceutical business."—From the Foreword by Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India

• Foreword by Dhruv Galgotia 1. Overview of the Pharmaceutical Marketplace 2. Big Pharma and BRIC Health Systems: Policy and Management Dilemma 3. Affiliate Marketing and the Symbiotic Relationship in the Pharma Industry 4. Empathic Innovation in the Healthcare Industry 5. Recent Trends in the Knowledge-Based Economy of Patents 6. The Implications of Pharmacoeconomics in Pharmaceutical Manufacturing 7. Overview of the Marketing Strategies Adopted by Different Pharmaceutical Companies 8. Role of Patents in Economic Development and Integration 9. The Environment of Marketing Management in Transitory Businesses 10. Clinical Trials for Drugs: Pharmacoeconomics‘s Function and Their Emerging Effective Outcomes 11. The Implications of Pharma Marketing to Improve Return on Investment (ROI) 12. Government Healthcare Initiatives and the Demand for Pharmaceuticals 13. Looking Forward to the Future of Pharma Marketing and Pharmacoeconomics 14. Pharma Marketing in India: Prospects and Challenges 15. Looking Forward Towards the Pharmacoeconomics and Pharma Marketing

Rishabha Malviya, PhD, is Associate Professor of Pharmacy at the School of Medical and Allied Sciences, Galgotias University, Uttar Pradesh, India. He has authored many research and review papers and book chapters and edited over a dozen books. He also holds over 50 patents. He has been included in the World’s Top 2% Scientists list by Elsevier BV and Stanford University. He is a reviewer, editor, and editorial board member of more than 50 national and international journals.Pramod Kumar Srivastava, PhD, MBA, is Professor at the School of Business at Galgotias University, Greater Noida, India. He has over 16 years of experience in academics and research. He has organized and conducted management development programs, consultancy, seminars, conferences, NGO fairs, workshops, and counseling sessions and has prepared reports on feasibility of production units in India.Swati Verma, MPharm, is working in the Department of Pharmacy in the School of Medical and Allied Sciences at Galgotias University, Uttar Pradesh, India. Her areas of interest are computeraided drug design, analytical chemistry, targeted drug delivery, and nanoformulation. She has authored several book chapters and review papers and edited two books.Shashikant Srivastava, PhD, is Assistant Professor at the Indian Institute of Management, Sirmaur, India. He is a course instructor for subjects such as critical readings of seminal works (PhD), information technology concepts (MBA), big data analytics (MBA), and digital marketing analytics and optimization (MBA). His research expertise is in information economics, information security, data analytics, blockchain, organization and management theory, and technology and innovation management. His research expertise in these domains is both quantitative and qualitative. He has authored a number of papers in national and international journals.

"Of immense use as the authors highlight the overall ethnography of big pharma in the healthcare sector, with the opportunities and challenges in the outside world. I believe that after reading the book, readers will have a picture of the marketing strategies to be adopted to boost the pharmaceutical business."—From the Foreword by Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India

• Foreword by Dhruv Galgotia 1. Overview of the Pharmaceutical Marketplace 2. Big Pharma and BRIC Health Systems: Policy and Management Dilemma 3. Affiliate Marketing and the Symbiotic Relationship in the Pharma Industry 4. Empathic Innovation in the Healthcare Industry 5. Recent Trends in the Knowledge-Based Economy of Patents 6. The Implications of Pharmacoeconomics in Pharmaceutical Manufacturing 7. Overview of the Marketing Strategies Adopted by Different Pharmaceutical Companies 8. Role of Patents in Economic Development and Integration 9. The Environment of Marketing Management in Transitory Businesses 10. Clinical Trials for Drugs: Pharmacoeconomics‘s Function and Their Emerging Effective Outcomes 11. The Implications of Pharma Marketing to Improve Return on Investment (ROI) 12. Government Healthcare Initiatives and the Demand for Pharmaceuticals 13. Looking Forward to the Future of Pharma Marketing and Pharmacoeconomics 14. Pharma Marketing in India: Prospects and Challenges 15. Looking Forward Towards the Pharmacoeconomics and Pharma Marketing

Rishabha Malviya, PhD, is Associate Professor of Pharmacy at the School of Medical and Allied Sciences, Galgotias University, Uttar Pradesh, India. He has authored many research and review papers and book chapters and edited over a dozen books. He also holds over 50 patents. He has been included in the World’s Top 2% Scientists list by Elsevier BV and Stanford University. He is a reviewer, editor, and editorial board member of more than 50 national and international journals.Pramod Kumar Srivastava, PhD, MBA, is Professor at the School of Business at Galgotias University, Greater Noida, India. He has over 16 years of experience in academics and research. He has organized and conducted management development programs, consultancy, seminars, conferences, NGO fairs, workshops, and counseling sessions and has prepared reports on feasibility of production units in India.Swati Verma, MPharm, is working in the Department of Pharmacy in the School of Medical and Allied Sciences at Galgotias University, Uttar Pradesh, India. Her areas of interest are computeraided drug design, analytical chemistry, targeted drug delivery, and nanoformulation. She has authored several book chapters and review papers and edited two books.Shashikant Srivastava, PhD, is Assistant Professor at the Indian Institute of Management, Sirmaur, India. He is a course instructor for subjects such as critical readings of seminal works (PhD), information technology concepts (MBA), big data analytics (MBA), and digital marketing analytics and optimization (MBA). His research expertise is in information economics, information security, data analytics, blockchain, organization and management theory, and technology and innovation management. His research expertise in these domains is both quantitative and qualitative. He has authored a number of papers in national and international journals.

"Of immense use as the authors highlight the overall ethnography of big pharma in the healthcare sector, with the opportunities and challenges in the outside world. I believe that after reading the book, readers will have a picture of the marketing strategies to be adopted to boost the pharmaceutical business."—From the Foreword by Dhruv Galgotia, CEO, Galgotias University, Greater Noida, India

• Foreword by Dhruv Galgotia 1. Overview of the Pharmaceutical Marketplace 2. Big Pharma and BRIC Health Systems: Policy and Management Dilemma 3. Affiliate Marketing and the Symbiotic Relationship in the Pharma Industry 4. Empathic Innovation in the Healthcare Industry 5. Recent Trends in the Knowledge-Based Economy of Patents 6. The Implications of Pharmacoeconomics in Pharmaceutical Manufacturing 7. Overview of the Marketing Strategies Adopted by Different Pharmaceutical Companies 8. Role of Patents in Economic Development and Integration 9. The Environment of Marketing Management in Transitory Businesses 10. Clinical Trials for Drugs: Pharmacoeconomics‘s Function and Their Emerging Effective Outcomes 11. The Implications of Pharma Marketing to Improve Return on Investment (ROI) 12. Government Healthcare Initiatives and the Demand for Pharmaceuticals 13. Looking Forward to the Future of Pharma Marketing and Pharmacoeconomics 14. Pharma Marketing in India: Prospects and Challenges 15. Looking Forward Towards the Pharmacoeconomics and Pharma Marketing